Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 May;152(5):1299–1311.

Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.

S Visonneau 1, A Cesano 1, M H Torosian 1, E J Miller 1, D Santoli 1
PMCID: PMC1858587  PMID: 9588898

Abstract

We evaluated the growth and metastatic potential of two human breast cancer cell lines and 16 patient-derived biopsy specimens, representing the most common histological types of breast carcinomas, upon subcutaneous implantation into severe combined immunodeficient (SCID) mice. The method of engraftment we used, based on implantation of intact tissue specimens and complete immunosuppression of the host, provided an easier system to grow human breast carcinoma specimens in mouse models and resulted in a 50% success rate of tumor take. No correlation was found between growth in SCID mice and pathological diagnosis, grading, or estrogen/progesterone receptor expression by the tumor biopsy specimen. Serial passage of the tumor fragments in SCID mice resulted in increased metastasis rates and more rapid emergence of a palpable tumor mass. A tumor from a patient with infiltrating ductal carcinoma, which grew aggressively and metastasized in 100% of the female SCID mice, was also successfully engrafted in 100% of nonobese diabetic (NOD)/SCID female mice, but systemic spread was minimal. Fragments of the same tumor grew in only 33% of male SCID mice with very limited metastases. A strong correlation (r = 0.997) was observed between tumor burden and the presence of soluble (serum) interleukin-2 receptor, a marker associated with a subset of human breast tumors. All together, these data indicate the usefulness of SCID/human breast tumor xenografts for measuring tumor progression and evaluating novel therapeutic approaches to breast cancer.

Full text

PDF
1299

Images in this article

1303Figure 1
on p.1303
1304Figure 2
on p.1304
1305Figure 3
on p.1305
1307Figure 5
on p.1307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brünner N., Osborne C. K., Spang-Thomsen M. Endocrine therapy of human breast cancer grown in nude mice. Breast Cancer Res Treat. 1987 Dec;10(3):229–242. doi: 10.1007/BF01805760. [DOI] [PubMed] [Google Scholar]
  2. Castro J. E., Cass W. Maintenance of human tumours and tissues in immunosuppressed mice. Br J Surg. 1974 Jun;61(6):421–426. doi: 10.1002/bjs.1800610602. [DOI] [PubMed] [Google Scholar]
  3. Cesano A., Hoxie J. A., Lange B., Nowell P. C., Bishop J., Santoli D. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias. Oncogene. 1992 May;7(5):827–836. [PubMed] [Google Scholar]
  4. Cesano A., Visonneau S., Cioé L., Clark S. C., Rovera G., Santoli D. Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach. J Clin Invest. 1994 Sep;94(3):1076–1084. doi: 10.1172/JCI117422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clarke R. Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat. 1996;39(1):69–86. doi: 10.1007/BF01806079. [DOI] [PubMed] [Google Scholar]
  6. Cohen N. D., Hilf R. Influence of insulin on growth and metabolism of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors. Cancer Res. 1974 Dec;34(12):3245–3252. [PubMed] [Google Scholar]
  7. Deeks S., Richards J., Nandi S. Maintenance of normal rat mammary epithelial cells by insulin and insulin-like growth factor 1. Exp Cell Res. 1988 Feb;174(2):448–460. doi: 10.1016/0014-4827(88)90314-x. [DOI] [PubMed] [Google Scholar]
  8. Dixon A. R., Jönrup I., Jackson L., Chan S. Y., Badley R. A., Blamey R. W. Serological monitoring of advanced breast cancer treated by systemic cytotoxic using a combination of ESR, CEA, and CA 15.3: fact or fiction? Dis Markers. 1991 May-Aug;9(3-4):167–174. [PubMed] [Google Scholar]
  9. Dnistrian A. M., Schwartz M. K., Greenberg E. J., Smith C. A., Schwartz D. C. CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. Clin Chim Acta. 1991 Aug 30;200(2-3):81–93. doi: 10.1016/0009-8981(91)90080-v. [DOI] [PubMed] [Google Scholar]
  10. Eskelinen M., Kataja V., Hämäläinen E., Kosma V. M., Penttilä I., Alhava E. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer. Anticancer Res. 1997 Mar-Apr;17(2B):1231–1234. [PubMed] [Google Scholar]
  11. Garofalo A., Chirivi R. G., Scanziani E., Mayo J. G., Vecchi A., Giavazzi R. Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. Invasion Metastasis. 1993;13(2):82–91. [PubMed] [Google Scholar]
  12. Giovanella B. C., Fogh J. The nude mouse in cancer research. Adv Cancer Res. 1985;44:69–120. doi: 10.1016/s0065-230x(08)60026-3. [DOI] [PubMed] [Google Scholar]
  13. Klein B., Levin I., Kfir B., Mishaeli M., Shapira J., Klein T. The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients. Tumour Biol. 1995;16(5):290–296. [PubMed] [Google Scholar]
  14. Kubota T., Yamaguchi H., Watanabe M., Yamamoto T., Takahara T., Takeuchi T., Furukawa T., Kase S., Kodaira S., Ishibiki K. Growth of human tumor xenografts in nude mice and mice with severe combined immunodeficiency (SCID). Surg Today. 1993;23(4):375–377. doi: 10.1007/BF00309059. [DOI] [PubMed] [Google Scholar]
  15. Lane E. B., Alexander C. M. Use of keratin antibodies in tumor diagnosis. Semin Cancer Biol. 1990 Jun;1(3):165–179. [PubMed] [Google Scholar]
  16. Lissoni P., Barni S., Rovelli F., Viviani S., Maestroni G. J., Conti A., Tancini G. The biological significance of soluble interleukin-2 receptors in solid tumors. Eur J Cancer. 1990 Jan;26(1):33–36. doi: 10.1016/0277-5379(90)90253-p. [DOI] [PubMed] [Google Scholar]
  17. Mackinnon S., Barnett L., Bourhis J. H., Black P., Heller G., O'Reilly R. J. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood. 1992 Dec 15;80(12):3235–3241. [PubMed] [Google Scholar]
  18. Marshall E. Epidemiology. Search for a killer: focus shifts from fat to hormones. Science. 1993 Jan 29;259(5095):618–621. doi: 10.1126/science.8430308. [DOI] [PubMed] [Google Scholar]
  19. Mehta R. R., Graves J. M., Hart G. D., Shilkaitis A., Das Gupta T. K. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat. 1993;25(1):65–71. doi: 10.1007/BF00662402. [DOI] [PubMed] [Google Scholar]
  20. Miller F. R., Medina D., Heppner G. H. Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res. 1981 Oct;41(10):3863–3867. [PubMed] [Google Scholar]
  21. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982 Nov;31(1):11–24. doi: 10.1016/0092-8674(82)90400-7. [DOI] [PubMed] [Google Scholar]
  22. Outzen H. C., Custer R. P. Growth of human normal and neoplastic mammary tissues in the cleared mammary fat pad of the nude mouse. J Natl Cancer Inst. 1975 Dec;55(6):1461–1466. doi: 10.1093/jnci/55.6.1461. [DOI] [PubMed] [Google Scholar]
  23. Ozzello L., Sordat M. Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice. Eur J Cancer. 1980 Apr;16(4):553–559. doi: 10.1016/0014-2964(80)90235-2. [DOI] [PubMed] [Google Scholar]
  24. Phillips R. A., Jewett M. A., Gallie B. L. Growth of human tumors in immune-deficient scid mice and nude mice. Curr Top Microbiol Immunol. 1989;152:259–263. doi: 10.1007/978-3-642-74974-2_31. [DOI] [PubMed] [Google Scholar]
  25. Price J. E. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat. 1996;39(1):93–102. doi: 10.1007/BF01806081. [DOI] [PubMed] [Google Scholar]
  26. Price J. E., Polyzos A., Zhang R. D., Daniels L. M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990 Feb 1;50(3):717–721. [PubMed] [Google Scholar]
  27. Rae-Venter B., Reid L. M. Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture. Cancer Res. 1980 Jan;40(1):95–100. [PubMed] [Google Scholar]
  28. Rohlik Q. T., Adams D., Kull F. C., Jr, Jacobs S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun. 1987 Nov 30;149(1):276–281. doi: 10.1016/0006-291x(87)91635-4. [DOI] [PubMed] [Google Scholar]
  29. Sakakibara T., Xu Y., Bumpers H. L., Chen F. A., Bankert R. B., Arredondo M. A., Edge S. B., Repasky E. A. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am. 1996 Sep-Oct;2(5):291–300. [PubMed] [Google Scholar]
  30. Schackert G., Price J. E., Bucana C. D., Fidler I. J. Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice. Int J Cancer. 1989 Nov 15;44(5):892–897. doi: 10.1002/ijc.2910440524. [DOI] [PubMed] [Google Scholar]
  31. Sebesteny A., Taylor-Papadimitriou J., Ceriani R., Millis R., Schmitt C., Trevan D. Primary human breast carcinomas transplantable in the nude mouse. J Natl Cancer Inst. 1979 Dec;63(6):1331–1337. [PubMed] [Google Scholar]
  32. Sharkey F. E., Fogh J. Metastasis of human tumors in athymic nude mice. Int J Cancer. 1979 Dec 15;24(6):733–738. doi: 10.1002/ijc.2910240605. [DOI] [PubMed] [Google Scholar]
  33. Shultz L. D., Schweitzer P. A., Christianson S. W., Gott B., Schweitzer I. B., Tennent B., McKenna S., Mobraaten L., Rajan T. V., Greiner D. L. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995 Jan 1;154(1):180–191. [PubMed] [Google Scholar]
  34. Sweeney T. M., Kibbey M. C., Zain M., Fridman R., Kleinman H. K. Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases. Cancer Metastasis Rev. 1991 Oct;10(3):245–254. doi: 10.1007/BF00050795. [DOI] [PubMed] [Google Scholar]
  35. Taylor-Papadimitriou J., Berdichevsky F., D'Souza B., Burchell J. Human models of breast cancer. Cancer Surv. 1993;16:59–78. [PubMed] [Google Scholar]
  36. Thompson E. W., Brünner N., Torri J., Johnson M. D., Boulay V., Wright A., Lippman M. E., Steeg P. S., Clarke R. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis. 1993 Jan;11(1):15–26. doi: 10.1007/BF00880062. [DOI] [PubMed] [Google Scholar]
  37. Visonneau S., Cesano A., Tepper S. A., Scimeca J. A., Santoli D., Kritchevsky D. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res. 1997 Mar-Apr;17(2A):969–973. [PubMed] [Google Scholar]
  38. Visonneau S., Cesano A., Torosian M. H., Santoli D. Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice. Clin Cancer Res. 1997 Sep;3(9):1491–1500. [PubMed] [Google Scholar]
  39. Zietman A. L., Sugiyama E., Ramsay J. R., Silobrcic V., Yeh E. T., Sedlacek R. S., Suit H. D. A comparative study on the xenotransplantability of human solid tumors into mice with different genetic immune deficiencies. Int J Cancer. 1991 Mar 12;47(5):755–759. doi: 10.1002/ijc.2910470522. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES